Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.
Steeg
P S
PS
Women's Cancers Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Clare
S E
SE
Lawrence
J A
JA
Zhou
Q
Q
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry*; D002278:Carcinoma in Situ / Q000737:chemistry* / Q000235:genetics; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry / Q000235:genetics; D056741:Cyclin D; D016213:Cyclins / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D015336:Molecular Probe Techniques; D011230:Precancerous Conditions / Q000737:chemistry* / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis
D014408:Biomarkers, Tumor; D056741:Cyclin D; D016213:Cyclins; D016159:Tumor Suppressor Protein p53